Search

everythinglearnresearchcommunity

for

Search:↓

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

The DQB1*03 allele is linked to higher alopecia areata risk in Italians.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

A genetic marker linked to a type of hair loss was found in most patients studied.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Inflammatory acne damages skin stem cells and reduces their growth, leading to atrophic acne scars.

A woman with lupus also developed a severe skin condition linked to a genetic factor.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

Cardiovascular drugs can cause various skin problems, so recognizing these reactions is important.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.